A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

Recruiting now · Phase 1

Conditions studied: Healthy

In brief

This goal of this trial is to learn about two medicines, enlicitide and rosuvastatin, in healthy people. Researchers will compare the amounts of enlicitide and rosuvastatin in a person's body over time, when they are given as separate medicines and when they are combined into one tablet.

Key facts

Study ID

NCT07300280

Run by

Merck Sharp & Dohme LLC

People needed

60

Starts

2025-12-29

Expected to finish

2026-10-21

Last updated by the study team

2026-06-09

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Is unable to refrain from or anticipates the use of any drugs, including prescription and non-prescription medications, herbal remedies, or vitamin supplements beginning 14 days prior to study entry
• Is a female participant of childbearing potential

Where it is running

• Celerion ( Site 0001) — Tempe, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.